Cargando…

Detection of prognostic factors in metastatic breast cancer

BACKGROUND: The aim of this study was to detect prognostic factors in recurrent breast cancer metastasis. MATERIALS AND METHODS: This retrospective cohort study employed data from 996 breast cancer patients of Isfahan Seyed-o-Shohada research center from 1998 to 2010. Stratified Cox proportional haz...

Descripción completa

Detalles Bibliográficos
Autores principales: Tazhibi, Mehdi, Fayaz, Mahsa, Mokarian, Fariborz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793372/
https://www.ncbi.nlm.nih.gov/pubmed/24124424
_version_ 1782286960367239168
author Tazhibi, Mehdi
Fayaz, Mahsa
Mokarian, Fariborz
author_facet Tazhibi, Mehdi
Fayaz, Mahsa
Mokarian, Fariborz
author_sort Tazhibi, Mehdi
collection PubMed
description BACKGROUND: The aim of this study was to detect prognostic factors in recurrent breast cancer metastasis. MATERIALS AND METHODS: This retrospective cohort study employed data from 996 breast cancer patients of Isfahan Seyed-o-Shohada research center from 1998 to 2010. Stratified Cox proportional hazards model, marginal approach, was used to evaluate the prognostic value of estrogen receptor, progesterone receptor, tumor protein 53, human epidermal growth factor receptor type 2, diagnosis age, nodal ratio, tumor size, antigen Ki67, and cathepsin D. Survival curves were plotted using Kaplan-Meier method and log-rank test was carried out to compare survival in two categories of nodal ratio (≤0.25 vs. >0.25). RESULTS: In simple Cox regression model, age (P = 0.037), nodal ratio (P < 0.0001), and Ki67 (P = 0.032) were associated with hazard of distant metastasis. Multiple analysis showed that patients with greater nodal ratio had significantly higher adjusted hazard of recurrent metastasis (Hazard ratio: 2.756, 95% Confidence interval: 1.017-7.467; P = 0.046). Tumor size was not an independent prognostic factor for recurrent metastasis. Comparing survival curves, there was significant difference between two categories of nodal ratio in the first (P < 0.0001), second (P < 0.0001) and third (P = 0.024) metastasis; survival was higher in-patients with nodal ratio <0.25. CONCLUSION: Our findings indicate that tumor size was insignificant; this raises the question about conventional premise of being a major prognostic factor for distant metastasis. Furthermore, nodal ratio is suggested to clinicians as a prognostic variable in follow-up of breast cancer patients; patients with higher nodal ratio have greater hazard of distant metastasis.
format Online
Article
Text
id pubmed-3793372
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37933722013-10-11 Detection of prognostic factors in metastatic breast cancer Tazhibi, Mehdi Fayaz, Mahsa Mokarian, Fariborz J Res Med Sci Original Article BACKGROUND: The aim of this study was to detect prognostic factors in recurrent breast cancer metastasis. MATERIALS AND METHODS: This retrospective cohort study employed data from 996 breast cancer patients of Isfahan Seyed-o-Shohada research center from 1998 to 2010. Stratified Cox proportional hazards model, marginal approach, was used to evaluate the prognostic value of estrogen receptor, progesterone receptor, tumor protein 53, human epidermal growth factor receptor type 2, diagnosis age, nodal ratio, tumor size, antigen Ki67, and cathepsin D. Survival curves were plotted using Kaplan-Meier method and log-rank test was carried out to compare survival in two categories of nodal ratio (≤0.25 vs. >0.25). RESULTS: In simple Cox regression model, age (P = 0.037), nodal ratio (P < 0.0001), and Ki67 (P = 0.032) were associated with hazard of distant metastasis. Multiple analysis showed that patients with greater nodal ratio had significantly higher adjusted hazard of recurrent metastasis (Hazard ratio: 2.756, 95% Confidence interval: 1.017-7.467; P = 0.046). Tumor size was not an independent prognostic factor for recurrent metastasis. Comparing survival curves, there was significant difference between two categories of nodal ratio in the first (P < 0.0001), second (P < 0.0001) and third (P = 0.024) metastasis; survival was higher in-patients with nodal ratio <0.25. CONCLUSION: Our findings indicate that tumor size was insignificant; this raises the question about conventional premise of being a major prognostic factor for distant metastasis. Furthermore, nodal ratio is suggested to clinicians as a prognostic variable in follow-up of breast cancer patients; patients with higher nodal ratio have greater hazard of distant metastasis. Medknow Publications & Media Pvt Ltd 2013-04 /pmc/articles/PMC3793372/ /pubmed/24124424 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Tazhibi, Mehdi
Fayaz, Mahsa
Mokarian, Fariborz
Detection of prognostic factors in metastatic breast cancer
title Detection of prognostic factors in metastatic breast cancer
title_full Detection of prognostic factors in metastatic breast cancer
title_fullStr Detection of prognostic factors in metastatic breast cancer
title_full_unstemmed Detection of prognostic factors in metastatic breast cancer
title_short Detection of prognostic factors in metastatic breast cancer
title_sort detection of prognostic factors in metastatic breast cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793372/
https://www.ncbi.nlm.nih.gov/pubmed/24124424
work_keys_str_mv AT tazhibimehdi detectionofprognosticfactorsinmetastaticbreastcancer
AT fayazmahsa detectionofprognosticfactorsinmetastaticbreastcancer
AT mokarianfariborz detectionofprognosticfactorsinmetastaticbreastcancer